Mirone V et al, 2014: Clinical aspects of antimicrobial prophylaxis for invasive urological procedures.

Mirone V, Franco M


The essential value of antimicrobial prophylaxis is to defend the patient undergoing invasive diagnostic procedures or surgery against infectious complications by reducing the bacterial load. Escherichia coli remains the predominant uropathogen (70-80%) isolated in acute community-acquired uncomplicated infections, followed by Staphylococcus saprophyticus (10 to 15%). Klebsiella, Enterobacter, Proteus species, and enterococci infrequently cause uncomplicated cystitis and pyelonephritis. The pathogens traditionally associated with UTI are altering many of their features, particularly because of antimicrobial resistance. Currently, only transurethral resection of prostate and prostate biopsy has been well studied and has high and moderately high levels of evidence in favor of using antibiotic prophylaxis. Other urological interventions have not been well studied. The moderate to low evidence suggests that there is no need for antibiotic prophylaxis in cystoscopy, urodynamic investigations, and extracorporeal shock-wave lithotripsy, whereas the low evidence favors the use of antibiotic prophylaxis for therapeutic ureterorenoscopy and percutaneous nephrolithotomy. The scarce data from studies on transurethral resection of bladder tumors cannot provide a definitive indication for antibiotic prophylaxis for this intervention.

J Chemother. 2014 Oct;26 Suppl 1:S1-S13. doi:10.1179/1120009X14Z.000000000232.


Comments 1

Peter Alken on Thursday, April 30 2015 12:58

No online article available via Karolinska Institutet and Heidelberg University.

No online article available via Karolinska Institutet and Heidelberg University.
Monday, September 28 2020

By accepting you will be accessing a service provided by a third-party external to

Linkedin Channel Facebook Channel Instagram Channel Pinterest Channel Youtube Channel